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Abstract
Background: We have created a software implementation of a published and verified method for
assigning probabilities to potential phosphorylation sites on peptides using mass spectrometric
data. Our tool, named PhosCalc, determines the number of possible phosphorylation sites and
calculates the theoretical masses for the b and y fragment ions of a user-provided peptide sequence.
A corresponding user-provided mass spectrum is examined to determine which putative b and y
ions have support in the spectrum and a probability score is calculated for each combination of
phosphorylation sites.
Findings: We test the implementation using spectra of phosphopeptides from bovine beta-casein
and we compare the results from the implementation to those from manually curated and verified
phosphopeptides from our own experiments. We find that the PhosCalc scores are capable of
helping a user to identify phosphorylated sites and can remove a bottleneck in high throughput
proteomics analyses.
Conclusion: PhosCalc is available as a web-based interface for examining up to 100 peptides and
as a downloadable tool for examining larger numbers of peptides. PhosCalc can be used to speed
up identification of phosphorylation sites and can be easily integrated into data handling pipelines
making it a very useful tool for those involved in phosphoproteomic research.
Findings
Challenges of detecting phosphorylated residues in mass 
spectrometer data
Phosphorylation is probably the most common of protein
post translational modifications (PTMs), with 30% of
eukaryotic proteins estimated to be modified this way [1].
Phosphorylation is essential to the cell by playing a cen-
tral role in signal transduction cascades, regulation of pro-
tein activity and protein-protein interactions. Therefore,
protein phosphorylation is one of the most intensely
studied PTMs. Protein phosphorylation can be detected as
a mass shift (+79.99 Da) in mass spectra, which corre-
sponds to the addition of HPO3 to a peptide, generally at
serine, threonine or tyrosine residues. In the mass spec-
trometer, peptides fragment in predictable ways and pro-
grams such as MASCOT [2] use algorithms to match
predicted fragmentation patterns of peptides from
sequence databases to that observed in MS spectra. While
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do not explicitly compare the evidence that may support
localisation of a modification to a specific residue rather
than a neighbouring position. Nor are they explicit when
the data cannot distinguish between alternatives. As phos-
phorylation may occur at rather common amino acid res-
idues, it is not unusual for a peptide to contain several
possible sites. The evidence that allows one to discrimi-
nate between two possibilities can be as low as one or two
peaks in a mass spectrum. Alternatively, if the potential
sites are well separated on the peptide, there may be direct
evidence in the form of several well identified peaks to
support one site over another.
It is important to be explicit about the level of confidence
a mass spectrum can provide for a particular phosphoryla-
tion site because this information has a large impact on
subsequent laboratory work (for example, identifying tar-
gets for site-directed mutagenesis). However, it is hard to
evaluate MS data and accurately judge the information
provided by MS2 fragmentation spectra (MS2 spectra are
spectra from the first fragmentation, MS3 spectra are
selected from the MS2 fragmentation and so forth) with-
out time-consuming manual examination by experienced
personnel. The interpretation of mass spectra of phos-
phopeptides, particularly from ion trap instruments, is
further complicated by the tendency of phosphopeptides
to preferentially fragment at the labile phosphoester bond
(with neutral loss of -98 Da; H3PO4) often accompanied
by poor fragmentation along the peptide backbone. This
problem can be addressed (in ion traps) by a further frag-
mentation event (MS3) on the neutral loss product ion
produced in the MS2 fragmentation event.
An algorithm to identify the phosphorylation site with best 
support in the spectrum
Recently an algorithm has been developed to provide fur-
ther support of peptide identifications from MS2 spectra
by comparison to MS3 [3]. The use of such an algorithm
in an analysis pipeline allows automatic phosphorylation
site identification or allows pre-selection of spectra for
manual identification. The method was subsequently
developed to validate the position of phosphorylation
from similar data [4]. The Olsen-Mann algorithm uses the
four most intense peaks per 100 m/z units in an MS2 or
MS3 spectrum, determines the theoretical masses of b and
y ions, and makes corrections for the masses of the ions
appropriate to whether the peptide sequence and spec-
trum are derived from an MS2 or MS3 spectrum. By calcu-
lating all possible b and y ions and all combinations of
phosphorylation site the algorithm is able to work on
peptide sequences with any number of potential phos-
phorylation sites. The algorithm counts the matches of the
four most intense peaks to each theoretical b and y ion. A
match is called whenever a peak from the spectrum falls
within a user-specified window of error around the theo-
retical ion mass; the mass accuracy of the mass spectrom-
eter used to generate the spectrum file should determine
the size of the appropriate window of error.
The probability of phosphorylation [3] at a site is given as
where
n = the total number of possible b and y ions,
k = the number of successful matches
P = 0.04 (as 4 peaks are allowed per 100 Da [2])
The probability score is
-10log(p(phos)) (2)
PhosCalc: an implementation of the algorithm
The algorithm has gained popularity as the number of
large scale projects increase and is incorporated into the
open source program MSQuant [4] but, surprisingly, is
not available as a stand-alone tool. Therefore, we have
implemented an exact version of the leading method
described and verified in [5] and used in other published
studies that calculates a probability based score for each
potential phosphorylation site. An existing implementa-
tion of the algorithm, Ascore [6], described in [7] is avail-
able but unlike PhosCalc is apparently tied to an
underlying human protein database for a compulsory
peptide identification step, removing its applicability to
data derived from other organisms. PhosCalc allows the
user to provide a peptide sequence from any source.
Unlike Ascore, PhosCalc will analyse data from MS2 and
MS3 spectra, not just MS2 spectra. PhosCalc also permits
the user to vary the window of error for peak matching
allowing for analysis of data from mass spectrometers of
different mass accuracy.
Our implementation, called PhosCalc, is available as a
web-tool or downloadable Perl script. In both versions,
the user must provide predicted peptide sequences, the
number of phosphorylation sites and a corresponding
mass spectrum in the Sequest DTA format. Data can be
entered via the simple web-interface for one to 100 pep-
tide sequences (Figure 1A); two files are required: a list of
peptide sequences and the zipped peak lists as dta files.
The standalone package can handle an unlimited number
of sequences. The PhosCalc tool returns an easily inter-
preted table showing probability of phosphorylation
(defined as p(phos) in formula 1) and score (defined in
p(phos)  
n
k
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and the number of peak matches in the spectrum for that
variant (Figure 2B). Our implementation uses mono-iso-
topic residue masses and the value for cysteine is unmodi-
fied (i.e., not alkylated). These values can be easily altered
in the downloadable version of PhosCalc. The variable
oxidation of methionine is included by 'M*' with the
addition of +15.99 Da. The mass value for phosphoryla-
tion is +79.9799 Da and is indicated by @ or # in the pep-
tide sequence. As MS3 spectra are triggered by loss of
phosphate plus water, the loss of 18.0105 Da is expected
to replace phosphorylation site in MS3 spectra.
Using PhosCalc
As a minimum, PhosCalc requires that the user provide a
peptide sequence that is thought to be phosphorylated
and a corresponding mass/intensity (dta) file from an MS
experiment. File formats for both the command line and
web versions are equivalent. The command line version
runs non-interactively from a single command line invo-
cation and creates output in a tab-delimited text file so
that the tool can be easily incorporated into pipelines and
workflows. The following description is of web-tool
usage; instructions on how to run the downloadable ver-
sion are available in the README file that comes with the
download.
• On the main PhosCalc page [8] insert into the box Pep-
tide Sequence (Figure 1A) the amino acid sequence of the
phosphorylated peptide and the markers representing the
potentially phosphorylated peptides. The amino acid
sequence of the peptide may be represented using the fol-
lowing standard IUPAC amino acid symbols: A, C, D, E, F,
G, H, I, K, L, M, N, P, Q, R, S, T, V, W or Y and the poten-
tially phosphorylated sites may be identified by insertion
of one of @, # or ^ (as far as PhosCalc is concerned these
symbols are interchangeable, but some upstream analysis
software make distinctions) after the putative phosphor-
ylation site suggested by the MS software; e.g., the peptide
sequence YNS#DTPEGVNSNWQR indicates that the pep-
tide is thought to carry a single phosphorylation, possibly
on the first serine (the calculator will assess and return the
Data input screens from the web version of PhosCalcFigure 1
Data input screens from the web version of PhosCalc.Page 3 of 9
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the peptide, irrespective of the putative phosphorylation
site suggested by the MS software). An oxidised methio-
nine residue may be indicated by entering 'M*'.
• Select the spectrum file to be evaluated (Figure 1A); this
is the output from the MS machine that represents the
mass peaks associated with this peptide. PhosCalc expects
that this is to be in .dta format file. A dta file is a mass/
intensity pair list that is a representation of the original
MS/MS spectrum and consists of two columns of decimal
numbers separated by one or more space characters and
ended by a carriage return. Examples are provided on the
web site and with the downloadable tool.
• Select a Window Size (Figure 1A). The hypothetical mass
peaks derived from the peptide sequence are matched
with the peaks from the mass spec by allowing a window
of error. This option defines the width of this window of
error.
• Select the Experiment Type (Figure 1A).
• Select whether the data came from an MS2 or MS3
experiment. If this is not selected, an MS2 experiment will
be assumed. The effect of selecting MS3 is that the dehy-
dration values will be used for #, @ and ^ symbols (-
18.0105 Da) not phosphorylation (+79.9799 Da).
Example of results of PhosCalc for the peptide FQSEEQQQTEDELQDK with annotated MS2 spectrum from SequestFigure 2
Example of results of PhosCalc for the peptide FQSEEQQQTEDELQDK with annotated MS2 spectrum from 
Sequest. A) PhosCalc output. B) Spectrum from a correct assignment. C) The same spectrum as 'B' with an incorrect assign-
ment. Peaks marked in blue and marked with empty circles are matched to b or y ions by Sequest and * marks those peaks that 
do not match with the incorrect position of phosphorylation. For clarity only singly charged b and y ions without further loss of 
OH or NH3 groups are annotated.
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tool (Figure 1B), a file is used to provide the peptide
sequences and their associated dta files. The Peptide +
Spectra file should consist of two tab separated columns.
The first column should contain the peptide sequence and
potential phosphorylation site information, formatted as
described here; the second column should contain the
name of the corresponding spectrum file. The file can eas-
ily be created using MS Excel or another spreadsheet pro-
gram and saved as a tab delimited text file. To prevent the
need to upload each .dta file individually, a zip archive of
the .dta files is used. To create a zip archive of the .dta files
listed in the Peptide + Spectra file on a Windows based
computer, there are numerous commercially available
archiving programs such as the Winzip program [9] which
can be used. On other operating systems such as MacOS X
and Linux variants, a version of zip should be installed by
default and the user should refer to the relevant documen-
tation. Note that only zip archives can be decompressed
by the server and other archive types will not work.
When run, the calculator will return the following results
(Figure 2A),
• phosphosite variant: a list of phosphosite variants of the
provided sequence, with the phosporylation sites consid-
ered in square brackets
• ions: the number of ions predicted from the peptide
sequence
• ions matched: the number of predicted ions whose mass
matched the masses in the dta file,
• p-values: the likelihood of this number of matches
(defined in formula 1)
• score: phosphorylation site score (defined in formula 2).
Efficacy of PhosCalc
To demonstrate the utility and limitations of PhosCalc,
we analysed a sample of the well characterised phospho-
protein, bovine beta-casein (Sigma). A sample of bovine
casein protein was digested with trypsin and analysed
with an LTQ mass spectrometer. Peptides were identified
using SEQUEST (ThermoFisher) on Bioworks 3.1 (full MS
details, SEQUEST search parameters and peptide scores
are available from the PhosCalc website). Phosphopep-
tides were identified from casein alpha-S1, beta-casein
variant CnH and casein alpha-S2. These are products of a
small related gene family and their inclusion in the prep-
aration from Sigma was expected; this was useful as it pro-
vided a range of well characterised phosphopeptides. The
observed phosphopeptides of casein αS1, αS2 and β are
detailed in Supplementary Table 1. All dta files and
Sequest scores can be downloaded from the PhosCalc
website.
Peptide FQSEEQQQTEDELQDK has only two possible
phosphorylation sites and they are well separated (Ser3
and Thr9). The output of PhosCalc clearly shows that the
MS2 and MS3 spectra strongly support the known phos-
phorylation site at Ser3 (Figures 2A and 3A). The first col-
umn shows the site being assessed, the second reports
how many ion peaks in the spectrum were evaluated (30)
and the third column contains the predicted b or y ions
matched (20 or 11 for Ser3 or Thr9, respectively). Finally
the p-value and score are also reported. So that experi-
enced MS users can assess how the numbers produced by
PhosCalc compare with visual representations of spectra,
two annotated versions of the same spectrum are pro-
vided for both the correct Ser3 assignment and the false
Thr9 (Figures 2A and 3A). In this case, as the spectrum is
good and the putative phosphorylation sites are well sep-
arated, several y ions (from y8 to y14; covering the por-
tion SEEQQQT of the peptide) do not match if the
phosphorylation is located on Thr9. Such matching is very
clear in the MS3 spectra annotated in Figures 3B and 3C.
While the differences are clear in this example it is not triv-
ial to make these comparisons manually and PhosCalc
can assist in identification of those spectra that do provide
sufficient evidence to discriminate between alternative
positions.
Of all the phosphopeptides identified, KTVDMESTEVFTK
provides the most detailed example because this peptide
should contain only one 'true' phosphorylation site and
has three alternative positions. The peptide was also
observed with an oxidised methionine residue (Figures 4B
and 4D) and with a mis-cleavage (K) (Figures 4A and 4C).
Figure 4A shows that only with the unoxidised form of
TVDMESTEVFTK can both MS2 and MS3 spectra distin-
guish between the correct phosphorylation site at Ser6
and Thr7. We recommend that at least two peaks should
be differential between alternative positions before the
phosphorylation site can be unambiguously identified.
This correlates to a difference of three orders of magnitude
Table 1: The sensitivities and specificities based on the 
distributions of PTM score for phosphorylated and non-
phosphorylated sites in known phosphopeptides.
Sensitivity (%) Specificity (%) PTM score cut-off
MS2 99 82 83.97
95 82.5 85.98
90 82.47 86.99
MS3 99 39 39.9
95 43.5 56.35
90 48 76.95Page 5 of 9
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support one phosphorylation site does not demonstrate a
weakness of PhosCalc but rather the limitations of the
mass spectra provided. As the two main alliterative sites
are next to each other, one could only expect very few ions
to be discriminatory between alternative sites.
To assess the ability of PhosCalc to distinguish between
phosphorylated and non-phosphorylated sites from
experimental data, we utilised the spectra of phosphopep-
tides from Arabidopsis thaliana which had been previously
identified by other researchers [10-12]. All spectra were
generated on an LTQ (ThermoFisher Corp.) using the con-
ditions detailed previously. The spectra can be down-
loaded as dta files from the PhosCalc website. For these
data an error tolerance of 0.4 Da was utilised. A total of 50
sites were analysed with PhosCalc and the PTM score of
known phospho-sites was compared with those of poten-
tial sites. Figure 5 shows the PTM score distributions of
each set. A clear and significant difference can be seen
between the PTM score distributions of non-phosphor-
ylated and phosphorylated sites in both MS2 (p < 2.51 ×
10-4) and MS3 (p < 0.049), showing that the implementa-
tion is capable of distinguishing between true phosphor-
ylated sites and non-phosphorylated sites.
We have also tested scores generated by PhosCalc with
scores generated by Ascore on sample datasets and find
that they are largely equivalent.
Example of results of PhosCalc for the peptide FQSEEQQQTEDELQDK with annotated MS3 spectrum from SequestFigure 3
Example of results of PhosCalc for the peptide FQSEEQQQTEDELQDK with annotated MS3 spectrum from 
Sequest. A) PhosCalc output. B) Spectrum from a correct assignment. C) The same spectrum as 'B' with an incorrect assign-
ment. Peaks marked in blue and marked with empty circles are matched to b or y ions by Sequest and * marks those peaks that 
do not match with the incorrect position of phosphorylation. For clarity only singly charged b and y ions without further loss of 
OH or NH3 groups are annotated, with the exception of the intense y14 2+ ion.
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lated sensitivities and specificities based on the distribu-
tions of PTM score for phosphorylated and non-
phosphorylated sites in known phosphopeptides, Table 1.
The implementation of the algorithm works extremely
well. We are able to obtain 99% sensitivity at a specificity
of 82% in spectra from MS2 experiments, using a PTM
score of 83.97 or higher. The implementation also works
well with MS3 spectra, allowing a specificity of 48% at a
sensitivity of 90% with a PTM score of 76.95 or higher.
Previously published studies have not used this algorithm
in isolation, rather it has been used in conjunction with
other measures such as MASCOT scores [2]. These pipe-
lines assign different confidence thresholds depending on
the study and type of MS. We advise that users should
implement additional scoring criteria particularly regard-
ing the sequence assignment and that PhosCalc scores and
cut-offs should be chosen with care.
The PhosCalc software is a fast and simple tool for reliably
identifying phosphorylation sites in mass spectrometer
data. PhosCalc should find utility in laboratories carrying
out phosphorylation site analyses at any scale. By using
our empirical sensitivity/specificity estimations and PTM
score cut-offs or those used in other studies or by compar-
ing with PTM scores in previously curated data sets from
in-house examinations, the software can be used to speed
up or automate decisions on phosphorylation site iden-
tity. With low-mass accuracy data, it should be noted that
when putative phosphorylation sites are close to each
other on the peptide, or if the mass spectrum contains few
peaks of reasonable intensity in the area of interest, there
may not be enough information (from that spectrum) to
discriminate between alternatives. It is important to be
aware of the limitations of the spectra obtained and
explicit about the levels of confidence in a particular phos-
phorylation site. The strength of PhosCalc is to enable
users to rapidly identify those spectra which provide
PhosCalc output for variations of KTVDMESTEVFTKFigure 4
PhosCalc output for variations of KTVDMESTEVFTK.Page 7 of 9
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from low-mass accuracy data.
Availability and Requirements
Project name: PhosCalc
Project home page: http://www.ayeaye.tsl.ac.uk/PhosCalc
Operating system(s): Platform independent
Programming language: Perl
Other requirements: For the download version, Perl 5.6 or
higher, Perl Math module, also under GPL and provided
with PhosCalc download
License: GPL 3
Restrictions to use by non-academics: none
Abbreviations
Amu: Atomic mass units; Da:= Dalton; PTM: Post-transla-
tional modification.
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Comparison of PTM score distributions generated by PhosCalcFigure 5
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